In hepatocellular carcinoma (HCC), CLCF1 enhances CXCL6 and TGF-β expression through the Akt/ERK1/2-STAT3 pathway, promoting stem cell traits and self-renewal in cancer cells (46) (Table 1). Here, AKT1 is linked to hepatocellular carcinoma.